TSHA

TSHA R&D Expense Growth

30.91%Fiscal year

Period ending:

TSHA FY R&D Growth (YoY)%
TSHA FY R&D Growth (YoY)3511.59%-418.01%
2019-12-312025-12-31

Source: Financial Modeling Prep (FMP). Annual fiscal periods. Dates are period ends; a fiscal year may differ from a calendar year. Growth compares with the corresponding period one year earlier.

TSHA r&d expense growth history

Year-over-year research & development expense growth. The available annual fiscal periods series contains 7 observations from Dec 31, 2019 to Dec 31, 2025.

Taysha Gene Therapies Inc R&D Expense Growth — Annual fiscal periods
Period endingR&D Expense Growth
30.9117%
16.244%
-37.7223%
-30.9027%
313.7052%
3,131.307%
0%

Compare r&d expense growth

All TSHA financial metrics · TSHA stock overview · How to interpret financial metrics

Data is provided for informational purposes only and does not constitute investment advice. Past performance is not indicative of future results.